Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004809

CEO and Chairman sold 219,569 shares at an average $7.29 ($1,600,417)

  • CEO and Chairman acquired 602,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +355,000 2,931,701 D
2025-03-05 Sale : show line 2 in the form −81,206 $6.98 $566,818 2,850,495 D
2025-03-05 Sale : show line 3 in the form −36,145 $6.99 $252,654 2,814,350 D
2025-03-05 Grant or award : show line 4 in the form +247,117 3,061,467 D
2025-03-06 Sale : show line 5 in the form −102,218 $7.64 $780,946 2,959,249 D
Open-market sales · 219,569 sh · avg $7.29 · $1,600,417
Loading xslF345X05/form4.xml…